Paula Antonia Ugalde Figueroa, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonectomy | 6 | 2024 | 1127 | 1.110 |
Why?
|
| Lung Neoplasms | 8 | 2024 | 13446 | 0.910 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2017 | 290 | 0.890 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2024 | 5380 | 0.760 |
Why?
|
| Bronchial Fistula | 1 | 2019 | 82 | 0.610 |
Why?
|
| Esophagectomy | 1 | 2022 | 478 | 0.600 |
Why?
|
| Pleural Diseases | 1 | 2019 | 138 | 0.590 |
Why?
|
| Carcinoid Tumor | 1 | 2017 | 224 | 0.490 |
Why?
|
| Analgesia | 1 | 2019 | 461 | 0.470 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 2893 | 0.410 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 1659 | 0.380 |
Why?
|
| Neoplasms, Second Primary | 1 | 2017 | 1056 | 0.320 |
Why?
|
| Immunotherapy | 1 | 2024 | 4752 | 0.300 |
Why?
|
| Laparoscopy | 1 | 2019 | 2037 | 0.290 |
Why?
|
| Thoracic Surgery | 2 | 2024 | 727 | 0.270 |
Why?
|
| Reoperation | 1 | 2017 | 4309 | 0.260 |
Why?
|
| Frozen Sections | 1 | 2024 | 152 | 0.220 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 11205 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6360 | 0.160 |
Why?
|
| Physicians, Women | 1 | 2024 | 512 | 0.150 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 992 | 0.150 |
Why?
|
| Thoracotomy | 1 | 2019 | 374 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2023 | 3597 | 0.120 |
Why?
|
| Propensity Score | 1 | 2022 | 1967 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2023 | 10087 | 0.090 |
Why?
|
| Humans | 13 | 2024 | 765823 | 0.090 |
Why?
|
| Survival Rate | 1 | 2023 | 12821 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1769 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2024 | 81505 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3834 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29915 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20680 | 0.040 |
Why?
|
| Africa | 1 | 2022 | 725 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 74853 | 0.030 |
Why?
|
| Leadership | 1 | 2024 | 1391 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 223016 | 0.030 |
Why?
|
| Female | 5 | 2024 | 396050 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 15398 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 9372 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 59506 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 65223 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 171178 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 223055 | 0.010 |
Why?
|
| Male | 1 | 2024 | 363740 | 0.000 |
Why?
|